Cytokine Recognition by Human Interleukin 5 Receptor

Vitamins and Hormones

Volumn 71, Issue , 2005, Pages 321-344

  Ishino, Tetsuya ^a   Robertson, Noreen ^a   Chaiken, Irwin ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DISULFIDE; EPITOPE; IL5RA PROTEIN, HUMAN; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 5 RECEPTOR ALPHA; INTERLEUKIN RECEPTOR; PEPTIDE LIBRARY;

ANIMAL; BINDING SITE; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOPLASM; DIMERIZATION; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN SECONDARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CELL MEMBRANE; CYTOKINES; CYTOPLASM; DIMERIZATION; DISULFIDES; EPITOPES; HUMANS; INTERLEUKIN-5; INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT; MODELS, MOLECULAR; PEPTIDE LIBRARY; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27744453929     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(05)71011-6     Document Type: Review

References (72)

1. Adachi T., and Alam R. The mechanism of IL-5 signal transduction. Am. J. Physiol. 275 (1998) C623-C633
2. Adachi T., Pazdrak K., Stafford S., and Alam R. The mapping of the Lyn kinase binding site of the common beta subunit of IL-3/granulocyte-macrophage colony-stimulating factor/IL-5 receptor. J. Immunol. 162 (1999) 1496-1501
3. Adachi T., Stafford S., Sur S., and Alam R. A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic inflammation. J. Immunol. 163 (1999) 939-946
4. Alam R., Pazdrak K., Stafford S., and Forsythe P. The interleukin-5/receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras-Raf-1-MAP kinase and the Jak-STAT pathways in eosinophils. Int. Arch. Allergy Immunol. 107 (1995) 226-227
5. Basten A., and Beeson P.B. Mechanism of eosinophilia. II. Role of the lymphocyte. J. Exp. Med. 131 (1970) 1288-1305
6. Baumgartner J.W., Wells C.A., Chen C.M., and Waters M.J. The role of the WSXWS equivalent motif in growth hormone receptor function. J. Biol. Chem. 269 (1994) 29094-29101
7. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87 (1990) 6934-6938
8. Boulanger M.J., Chow D.C., Brevnova E.E., and Garcia K.C. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 300 (2003) 2101-2104
9. Carr P.D., Gustin S.E., Church A.P., Murphy J.M., Ford S.C., Mann D.A., Woltring D.M., Walker I., Ollis D.L., and Young I.G. Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration. Cell 104 (2001) 291-300
10. Chaiken I., and Proudfoot A. "Structure of Interleukin-5." (1999), Marcel Dekker, New York
11. Chung K.F., van Rensen E., Stirling R., and Barnes P.J. IL-5 in asthma. Thorax 57 (2002) 751
12. Coffman R.L., Seymour B.W., Hudak S., Jackson J., and Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245 (1989) 308-310
13. Cornelis S., Fache I., Van der Heyden J., Guisez Y., Tavernier J., Devos R., Fiers W., and Plaetinck G. Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction. Eur. J. Immunol. 7 (1995) 1857-1864
14. de Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255 (1992) 306-312
15. Devos R., Guisez Y., Plaetinck G., Cornelis S., Tavernier J., van der Heyden J., Foley L.H., and Scheffler J.E. Covalent modification of the interleukin-5 receptor by isothiazolones leads to inhibition of the binding of interleukin-5. Eur. J. Biochem. 225 (1994) 635-640
16. Dickason R.R., and Huston D.P. Creation of a biologically active interleukin-5. Nature 379 (1996) 652-655
17. Elkins P.A., Christinger H.W., Sandowski Y., Sakal E., Gertler A., de Vos A.M., and Kossiakoff A.A. Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor. Nat. Struct. Biol. 7 (2000) 808-815
18. England B.P., Balasubramanian P., Uings I., Bethell S., Chen M.J., Schatz P.J., Yin Q., Chen Y.F., Whitehorn E.A., Tsavaler A., Martens C.L., Barrett R.W., and McKinnon M. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains. Proc. Natl. Acad. Sci. USA 97 (2000) 6862-6867
19. Fattah D., Quint D.J., Proudfoot A., O'Malley R., Zanders E.D., and Champion B.R. In vitro and in vivo studies with purified recombinant human interleukin 5. Cytokine 2 (1990) 112-121
20. Foster P.S., Hogan S.P., Yang M., Mattes J., Young I.G., Matthaei K.I., Kumar R.K., Mahalingam S., and Webb D.C. Interleukin-5 and eosinophils as therapeutic targets for asthma. Trends Mol. Med. 8 (2002) 162-167
21. Fuh G., Cunningham B.C., Fukunaga R., Nagata S., Goeddel D.V., and Wells J.A. Rational design of potent antagonists to the human growth hormone receptor. Science 256 (1992) 1677-1680
22. Geijsen N., Uings I.J., Pals C., Armstrong J., McKinnon M., Raaijmakers J.A., Lammers J.W., Koenderman L., and Coffer P.J. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 293 (2001) 1136-1138
23. Goodall G.J., Bagley C.J., Vadas M.A., and Lopez A.F. A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors 8 (1993) 87-97
24. Graber P., Proudfoot A.E., Talabot F., Bernard A., McKinnon M., Banks M., Fattah D., Solari R., Peitsch M.C., and Wells T.N. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation. J. Biol. Chem. 270 (1995) 15762-15769
25. Hitoshi Y., Yamaguchi N., Korenaga M., Mita S., Tominaga A., and Takatsu K. In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice. Int. Immunol. 3 (1991) 135-139
26. Ishino T., Pasut G., Scibek J., and Chaiken I. Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition. J. Biol. Chem. 279 (2004) 9547-9556
27. Itoh T., Liu R., Yokota T., Arai K.I., and Watanabe S. Definition of the role of tyrosine residues of the common beta subunit regulating multiple signaling pathways of granulocyte-macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 18 (1998) 742-752
28. Johanson K., Appelbaum E., Doyle M., Hensley P., Zhao B., Abdel-Meguid S.S., Young P., Cook R., Carr S., Matico R., Cusimano D., Dul E., Angelichio M., Brooks I., Winborne E., McDonnell P., Morton T., Bannett D., Sokoloski T., McNulty D., Rosenberg M., and Chaiken I. Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins. J. Biol. Chem. 270 (1995) 9459-9471
29. Kaushansky K. Hematopoietic growth factor mimetics. Ann. NY Acad. Sci. 938 (2001) 131-138
30. Koradi R., Billeter M., and Wuthrich K. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph 14 (1996) 29-32, 51-55.
31. Li C., Plugariu C.G., Bajgier J., White J.R., Liefer K.M., Wu S.J., and Chaiken I. Coiled coil miniprotein randomization on phage leads to charge pattern mimicry of the receptor recognition determinant of interleukin 5. J. Mol. Recog. 15 (2002) 33-43
32. Li J., Cook R., and Chaiken I. Mutants of single chain interleukin 5 show asymmetric recruitment of receptor alpha and betac subunits. J. Biol. Chem. 271 (1996) 31729-31734
33. Li J., Cook R., Dede K., and Chaiken I. Single chain human interleukin 5 and its asymmetric mutagenesis for mapping receptor binding sites. J. Biol. Chem. 271 (1996) 1817-1820
34. Li J., Cook R., Doyle M.L., Hensley P., McNulty D.E., and Chaiken I. Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function. Proc. Natl. Acad. Sci. USA 94 (1997) 6694-6699
35. Livnah O., Stura E.A., Middleton S.A., Johnson D.L., Jolliffe L.K., and Wilson I.A. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283 (1999) 987-990
36. Lopez A.F., Elliott M.J., Woodcock J., and Vadas M.A. GM-CSF, IL-3 and IL-5: Cross-competition on human haemopoietic cells. Immunol. Today 13 (1992) 495-500
37. Lowman H.B., Chen Y.M., Skelton N.J., Mortensen D.L., Tomlinson E.E., Sadick M.D., Robinson I.C., and Clark R.G. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions. Biochemistry 37 (1998) 8870-8878
38. Martinez-Moczygemba M., and Huston D.P. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J. Allergy Clin. Immunol. 112 (2003) 653-665
39. McClure B.J., Hercus T.R., Cambareri B.A., Woodcock J.M., Bagley C.J., Howlett G.J., and Lopez A.F. Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. Blood 101 (2003) 1308-1315
40. McKenzie A.N., Barry S.C., Strath M., and Sanderson C.J. Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules. EMBO J. 10 (1991) 1193-1199
41. McKinnon M., Banks M., Solari R., and Robertson G. "Interleukin-5: From Molecule to Drug Target for Asthma." (1999), Marcel Dekker, New York
42. Milburn M.V., Hassell A.M., Lambert M.H., Jordan S.R., Proudfoot A.E., Graber P., and Wells T.N. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature 363 (1993) 172-176
43. Morton T., Li J., Cook R., and Chaiken I. Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition. Proc. Natl. Acad. Sci. USA 92 (1995) 10879-10883
44. Mui A.L., Wakao H., O' Farrell A.M., Harada N., and Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 14 (1995) 1166-1175
45. Murata Y., Takaki S., Migita M., Kikuchi Y., Tominaga A., and Takatsu K. Molecular cloning and expression of the human interleukin 5 receptor. J. Exp. Med. 175 (1992) 341-351
46. Ogata N., Kikuchi Y., Kouro T., Tomonaga M., and Takatsu K. The activation of the JAK2/STAT5 pathway is commonly involved in signaling through the human IL-5 receptor. Int. Arch. Allergy Immunol. 114 (1997) 24-27
47. Ogata N., Kouro T., Yamada A., Koike M., Hanai N., Ishikawa T., and Takatsu K. JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and beta-c subunit, respectively, and are activated upon IL-5 stimulation. Blood 91 (1998) 2264-2271
48. Pan B., Li B., Russell S.J., Tom J.Y., Cochran A.G., and Fairbrother W.J. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor. J. Mol. Biol. 316 (2002) 769-787
49. Pazdrak K., Adachi T., and Alam R. Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival. J. Exp. Med. 186 (1997) 561-568
50. Pazdrak K., Justement L., and Alam R. Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J. Immunol. 155 (1995) 4454-4458
51. Pazdrak K., Olszewska-Pazdrak B., Stafford S., Garofalo R.P., and Alam R. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J. Exp. Med. 188 (1998) 421-429
52. Plaetinck G., Van der Heyden J., Tavernier J., Fache I., Tuypens T., Fischkoff S., Fiers W., and Devos R. Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells. J. Exp. Med. 172 (1990) 683-691
53. Rozwarski D.A., Gronenborn A.M., Clore G.M., Bazan J.F., Bohm A., Wlodawer A., Hatada M., and Karplus P.A. Structural comparisons among the short-chain helical cytokines. Structure 2 (1994) 159-173
54. Ruchala P., Varadi G., Ishino T., Scibek J., Bhattacharya M., Urbina C., Ryk D.V., Uings I., and Chaiken I. Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha. Biopolymers 73 (2004) 556-568
55. Sanderson C.J., and Urwin D. Interleukin-5: A drug target for allergic diseases. Curr. Opin. Invest. Drugs 1 (2000) 435-441
56. Scibek J.J., Evergren E., Zahn S., Canziani G.A., Van Ryk D., and Chaiken I.M. Biosensor analysis of dynamics of interleukin 5 receptor subunit beta(c) interaction with IL-5:IL-5R(alpha) complexes. Anal. Biochem. 307 (2002) 258-265
57. Sehmi R., and Denburg J.A. "Bone Marrow in Allergic Disease: The Role of Interleukin-5 as an Eosinophilopoietic Factor." (1999), Marcel Dekker, New York
58. Skelton N.J., Russell S., de Sauvage F., and Cochran A.G. Amino acid determinants of beta-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library. J. Mol. Biol. 316 (2002) 1111-1125
59. Stafford S., Lowell C., Sur S., and Alam R. Lyn tyrosine kinase is important for IL-5-stimulated eosinophil differentiation. J. Immunol. 168 (2002) 1978-1983
60. Stomski F.C., Sun Q., Bagley C.J., Woodcock J., Goodall G., Andrews R.K., Berndt M.C., and Lopez A.F. Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding. Mol. Cell. Biol. 16 (1996) 3035-3046
61. Stomski F.C., Woodcock J.M., Zacharakis B., Bagley C.J., Sun Q., and Lopez A.F. Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors. J. Biol. Chem. 273 (1998) 1192-1199
62. Takaki S., Kanazawa H., Shiiba M., and Takatsu K. A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Mol. Cell. Biol. 14 (1994) 7404-7413
63. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268 (1995) 251-255
64. Tavernier J., Devos R., Cornelis S., Tuypens T., Van der Heyden J., Fiers W., and Plaetinck G. A human high affinity interleukin-5 receptor (IL-5R) is composed of an IL-5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66 (1991) 1175-1184
65. Tavernier J., Tuypens T., Verhee A., Plaetinck G., Devos R., Van der Heyden J., Guisez Y., and Oefner C. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc. Natl. Acad. Sci. USA 92 (1995) 5194-5198
66. Uings I.J., Balasubramanian P., McLoughlin P.G., Yin Q., Dash L., Beresford A., Kearney S., Barrett R.W., McKinnon M., and England B.P. Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity. Cytokine 15 (2001) 10-19
67. van der Bruggen T., Caldenhoven E., Kanters D., Coffer P., Raaijmakers J.A., Lammers J.W., and Koenderman L. Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. Blood 85 (1995) 1442-1448
68. Walter M.R. Crystal structures of alpha-helical cytokine-receptor complexes: We've only scratched the surface. Biotechniques 33 Suppl. (2002) 46-57
69. Wardlaw A.J., Brightling C., Green R., Woltmann G., and Pavord I. Eosinophils in asthma and other allergic diseases. Br. Med. Bull. 56 (2000) 985-1003
70. Wrighton N.C., Farrell F.X., Chang R., Kashyap A.K., Barbone F.P., Mulcahy L.S., Johnson D.L., Barrett R.W., Jolliffe L.K., and Dower W.J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273 (1996) 458-464
71. Wu S.J., Li J., Tsui P., Cook R., Zhang W., Hu Y., Canziani G., and Chaiken I. Randomization of the receptor alpha chain recruitment epitope reveals a functional interleukin-5 with charge depletion in the CD loop. J. Biol. Chem. 274 (1999) 20479-20488
72. Zangrilli J., Robertson N., Shetty A., Wu J., Hastie A., Fish J.E., Litwack G., and Peters S.P. Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils. Clin. Exp. Immunol. 120 (2000) 12-21